119 related articles for article (PubMed ID: 32132050)
21. [Evaluation value of preoperative peripheral blood lymphocyte-to-monocyte ratio on the prognosis of patients with stage III colon cancer].
Chen J; Peng J; Fan W; Zhang R; Wang F; Zhou W; Xu D; Pan Z; Lu Z
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):73-78. PubMed ID: 30703797
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of Systemic Inflammatory Response Biomarkers in Patients Receiving Chemotherapy for Unresectable and Recurrent Advanced Gastric Cancer.
Namikawa T; Munekage E; Munekage M; Maeda H; Yatabe T; Kitagawa H; Kobayashi M; Hanazaki K
Oncology; 2016; 90(6):321-6. PubMed ID: 27225990
[TBL] [Abstract][Full Text] [Related]
23. The neutrophil-to-lymphocyte ratio (NLR) predicts short-term and long-term outcomes in gastric cancer patients.
Miyamoto R; Inagawa S; Sano N; Tadano S; Adachi S; Yamamoto M
Eur J Surg Oncol; 2018 May; 44(5):607-612. PubMed ID: 29478743
[TBL] [Abstract][Full Text] [Related]
24. Prognostic value of perioperative leukocyte count in resectable gastric cancer.
Chen XF; Qian J; Pei D; Zhou C; Røe OD; Zhu F; He SH; Qian YY; Zhou Y; Xu J; Xu J; Li X; Ping GQ; Liu YQ; Wang P; Guo RH; Shu YQ
World J Gastroenterol; 2016 Mar; 22(9):2818-27. PubMed ID: 26973420
[TBL] [Abstract][Full Text] [Related]
25. Systemic inflammation score as a preoperative prognostic factor for patients with pT2-T4 resectable gastric cancer: a retrospective study.
Matsumoto T; Ohki S; Kaneta A; Matsuishi A; Maruyama Y; Yamada L; Tada T; Hanayama H; Watanabe Y; Hayase S; Okayama H; Sakamoto W; Momma T; Saze Z; Kono K
BMC Surg; 2023 Jan; 23(1):8. PubMed ID: 36635689
[TBL] [Abstract][Full Text] [Related]
26. Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial.
Noh SH; Park SR; Yang HK; Chung HC; Chung IJ; Kim SW; Kim HH; Choi JH; Kim HK; Yu W; Lee JI; Shin DB; Ji J; Chen JS; Lim Y; Ha S; Bang YJ;
Lancet Oncol; 2014 Nov; 15(12):1389-96. PubMed ID: 25439693
[TBL] [Abstract][Full Text] [Related]
27. Impact of systemic inflammation on gastric cancer outcomes.
Liu X; Chen S; Liu J; Xu D; Li W; Zhan Y; Li Y; Chen Y; Zhou Z; Sun X
PLoS One; 2017; 12(3):e0174085. PubMed ID: 28358923
[TBL] [Abstract][Full Text] [Related]
28. Neutrophil count and the inflammation-based glasgow prognostic score predict survival in patients with advanced gastric cancer receiving first-line chemotherapy.
Li QQ; Lu ZH; Yang L; Lu M; Zhang XT; Li J; Zhou J; Wang XC; Gong JF; Gao J; Li J; Li Y; Shen L
Asian Pac J Cancer Prev; 2014; 15(2):945-50. PubMed ID: 24568523
[TBL] [Abstract][Full Text] [Related]
29. Preoperative neutrophil-to-lymphocyte ratio plus platelet-to-lymphocyte ratio in predicting survival for patients with stage I-II gastric cancer.
Sun X; Liu X; Liu J; Chen S; Xu D; Li W; Zhan Y; Li Y; Chen Y; Zhou Z
Chin J Cancer; 2016 Jun; 35(1):57. PubMed ID: 27342313
[TBL] [Abstract][Full Text] [Related]
30. The Prediction Value of the Systemic Inflammation Score for Oral Cavity Squamous Cell Carcinoma.
Eltohami YI; Kao HK; Lao WW; Huang Y; Abdelrahman M; Liao CT; Yen TC; Chang KP
Otolaryngol Head Neck Surg; 2018 Jun; 158(6):1042-1050. PubMed ID: 29336202
[TBL] [Abstract][Full Text] [Related]
31. Improvement of high-sensitivity inflammation-based Glasgow prognostic score by gastrectomy is a favorable prognostic factor in patients with gastric cancer.
Takeno S; Hashimoto T; Shibata R; Maki K; Shiwaku H; Yamana I; Yamashita R; Yamashita Y
Anticancer Res; 2014 Oct; 34(10):5695-702. PubMed ID: 25275076
[TBL] [Abstract][Full Text] [Related]
32. Pre-adjuvant chemotherapy leukocyte count may predict the outcome for advanced gastric cancer after radical resection.
Pei D; Zhu F; Chen X; Qian J; He S; Qian Y; Shen H; Liu Y; Xu J; Shu Y
Biomed Pharmacother; 2014 Mar; 68(2):213-7. PubMed ID: 24581723
[TBL] [Abstract][Full Text] [Related]
33. Efficacy of intraperitoneal and intravenous chemotherapy and left upper abdominal evisceration for advanced gastric cancer.
Nomura E; Niki M; Fujii K; Shinohara H; Nishiguchi K; Sonoda T; Tanigawa N
Gastric Cancer; 2001; 4(2):75-82. PubMed ID: 11706764
[TBL] [Abstract][Full Text] [Related]
34. Prealbumin and lymphocyte-based prognostic score, a new tool for predicting long-term survival after curative resection of stage II/III gastric cancer.
Shen Q; Liu W; Quan H; Pan S; Li S; Zhou T; Ouyang Y; Xiao H
Br J Nutr; 2018 Dec; 120(12):1359-1369. PubMed ID: 30370885
[TBL] [Abstract][Full Text] [Related]
35. Is adjuvant chemotherapy necessary in pT1N1 gastric cancer?
Shin HB; An JY; Lee SH; Choi YY; Kim JW; Sohn SS; Noh SH
BMC Cancer; 2017 Apr; 17(1):287. PubMed ID: 28431518
[TBL] [Abstract][Full Text] [Related]
36. [Clinical significance of prognostic nutritional index in patients with advanced gastric cancer].
Song S; Liu H; Xue Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Feb; 21(2):180-184. PubMed ID: 29492917
[TBL] [Abstract][Full Text] [Related]
37. Survival Outcomes of Two Phase 2 Studies of Adjuvant Chemotherapy with S-1 Plus Oxaliplatin or Capecitabine Plus Oxaliplatin for Patients with Gastric Cancer After D2 Gastrectomy.
Nakamura Y; Yamanaka T; Chin K; Cho H; Katai H; Terashima M; Misawa K; Hirao M; Yoshida K; Oki E; Sasako M; Emi Y; Bando H; Kawashima Y; Fukunaga T; Gotoh M; Ishibashi T; Shitara K
Ann Surg Oncol; 2019 Feb; 26(2):465-472. PubMed ID: 30456678
[TBL] [Abstract][Full Text] [Related]
38. Adverse prognostic impact of perioperative allogeneic transfusion on patients with stage II/III gastric cancer.
Kanda M; Kobayashi D; Tanaka C; Iwata N; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Nomoto S; Murotani K; Fujiwara M; Kodera Y
Gastric Cancer; 2016 Jan; 19(1):255-63. PubMed ID: 25563579
[TBL] [Abstract][Full Text] [Related]
39. The prognostic value of detecting symptomatic or asymptomatic recurrence in patients with gastric cancer after a curative gastrectomy.
Bilici A; Salman T; Oven Ustaalioglu BB; Unek T; Seker M; Aliustaoglu M; Gezen C; Unek T; Yavuzer D; Unlu M; Gumus M; Yilmaz U
J Surg Res; 2013 Mar; 180(1):e1-9. PubMed ID: 22520575
[TBL] [Abstract][Full Text] [Related]
40. Role of patient-, tumor- and systemic inflammatory response-related factors in predicting survival of patients with node-negative gastric cancer.
Qu J; Qu X; Li Z; Zhang J; Teng Y; Jin B; Zhao M; Yu P; Wang Z; Liu Y
Tumour Biol; 2017 Jun; 39(6):1010428317698374. PubMed ID: 28618960
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]